Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Stearoylethanolamide(N-(2-Hydroxyethyl)octadecanamide) is a cannabinoid compound present in the brains of humans, rats, and mice with pro-apoptotic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 36.00 | |
5 mg | In stock | $ 55.00 | |
10 mg | In stock | $ 89.00 | |
25 mg | In stock | $ 179.00 | |
50 mg | In stock | $ 286.00 | |
100 mg | In stock | $ 425.00 | |
500 mg | In stock | $ 982.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 61.00 |
Description | Stearoylethanolamide(N-(2-Hydroxyethyl)octadecanamide) is a cannabinoid compound present in the brains of humans, rats, and mice with pro-apoptotic activity. |
In vitro | Present in human, rat, and mouse brain in amounts comparable to the endocannabinoid anandamide (arachidonoylethanolamide; AEA), stearoylethanolamide (SEA) is an endocannabinoid-like compound with pro-apoptotic activity. Its regulation by NO is reported to be in a manner opposite to that observed for AEA[1]. |
Synonyms | N-(2-Hydroxyethyl)octadecanamide |
Molecular Weight | 327.55 |
Formula | C20H41NO2 |
CAS No. | 111-57-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (91.59 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Stearoylethanolamide 111-57-9 Apoptosis N-(2-Hydroxyethyl)octadecanamide inhibitor inhibit